Jump to Content

 

Master of Clinical Pharmacy

2008 | 2009 | 2010

Division of Health Sciences | School of Pharmacy and Medical Sciences

Program Code: IMCM

Program Level: Postgraduate

SATAC code: 4CM038

Home Campus: City East

Program Length (in EFTSL): 1.5

Program director/s

This program is only available by external study.  New international applicants should note that from 2010 the program will only be available for external study in their home country with the compulsory workshops located in Adelaide or Singapore (dependent upon numbers).  Continuing international students are able to complete the program onshore in Australia. 

External delivery for this program is based on written and online teaching materials supplemented by three all day workshops utilising case examples twice per course.

HOW TO APPLY

DOMESTIC STUDENTS ONLY

Applications to this program are online via SATAC's Gradstart portal.

INTERNATIONAL STUDENTS ONLY

Applications to this program are via UniSA's Apply Online portal. Applicants should note that this program is available only by external study in their home country with the compulsory workshops located in Adelaide or Singapore (dependent upon numbers). 

Aim

The program aims to produce clinical pharmacists capable of providing specialist pharmaceutical services in hospitals and other clinical environments, thereby enhancing the quality use of medicine. Graduates will be able to take a leading role in the decision making process of drug and drug product selection for individual patients, provide specialist drug information and education programs to patients and health care providers, effectively monitor a patient's therapy and critically evaluate clinical research.

Entry requirements

Australian applicants are required to:

International applicants (see Note 2) are required to:

Note 1:  to be considered equivalent to a Bachelor of Pharmacy degree, the award must have a principal focus on pharmacokinetics, applied pharmacology, disease pathophysiology and treatment. An award with a principal focus on pharmaceutical manufacturing will not be considered equivalent for entry to the program.

Note 2:  International applicants who wish to study this program are advised that this program is only available externally/on-line in the student's home country. International applicants wishing to study this program externally/on-line in their home country, must meet all entry requirements, including the English Language Requirements, and must provide proof of experience in a patient care environment.

In addition, international applicants who speak English as a foreign language must have obtained one of the following standards within the last two years prior to admission:

Note 3: Results from IELTS and TOEFL are valid for two years

Note 4: The University, through UniSA International, maintains a list of countries where English is commonly used and which would satisfy this criterion. This may include particular educational institutions within a given non-English speaking country where English is the language of instruction.

Content/structure

The program requires completion of 54 units of study comprising 36 units (core units) that provide the basic skills for clinical pharmacy practice followed by intensive pharmacotherapeutics/medication management instruction.  The final 18 units of the program comprise a choice of electives involving practical application of above skills in a practice environment, research skills, critical thinking, epidemiology, evidence based medicine or negotiated study.

Fee information

Fees for Domestic students: Commonwealth Supported
Fees for Commonwealth Supported Students are calculated at the course level. Click on individual courses in the schedule below to determine total program fees.


Program requirements

Course name Area + Cat. No. Units EFTSL
FIRST YEAR   
First Half (Study Period 1, 2 or 3)   
PHAR 50424.50.125
PHAR 50514.50.125
PHAR 50434.50.125
PHAR 50444.50.125
Second Half (Study Period 4, 5 or 6)   
PHAR 504590.250
PHAR 504690.250
SECOND YEAR   
First Half (Study Period 1, 2 or 3)   
Students must select 18 units from the following:   
MATH 50284.50.125
PHAR 505090.250
REHB 510290.250
HLTH 51414.50.125
HLTH 51314.50.125
HLTH 51454.50.125
HLTH 51464.50.125
HLTH 51474.50.125

Credit transfer

Credit for the Graduate Certificate in Pharmacy Practice or Graduate Diploma in Clinical Pharmacy
Graduates of the University of South Australia's Graduate Certificate in Pharmacy Practice or Graduate Diploma in Clinical Pharmacy wishing to upgrade to the Master of Clinical Pharmacy award will be granted full unit credit for courses completed in the Graduate Certificate or Graduate Diploma award.

Rules

  1. Credit for previous studies or exemption from work within courses may be granted in accordance with University policy. Maximum credit allowed is normally one third of the total units of the program.
  2. Students are required to satisfy the standards of dress and behaviour prescribed by institutions in which any professional placements are undertaken.  Failure to satisfy such requirements may prevent a student from completing the program.
  3. Academic performance will be monitored by the Program Management Committee.  Students must achieve an average mark of 55% (P1) in the courses to be allowed to continue their enrolment in the program.  This will be measured after the first three courses and continuously thereafter.
  4. Unless able to demonstrate proven extensive experience in clinical pharmacy practice, students will be expected to enrol in PHAR 5050 Medicine Management Clerkship.

Notes

  1. To be considered equivalent, the Bachelor of Pharmacy degree must have a principal focus on pharmacokinetics, applied pharmacology, disease pathophysiology and treatment.  A Bachelor of Pharmacy degree with a principal focus on pharmaceutical manufacturing will not be considered equivalent for entry into the program.
  2. The program aims to produce clinical pharmacists capable of providing specialist pharmaceutical services in hospitals and other clinical environments, thereby enhancing the quality use of medicines. The program builds on skills of practice developed as an undergraduate student and is therefore not a pathway to registration as a pharmacist in Australia.


top^